Fluorescent reporters of the histone acetyltransferase

Analytical Biochemistry

Volumn 380, Issue 1, 2008, Pages 106-110

  Wu, Jiang ^a   Zheng, Yujun George ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Chromatin modification; Epigenetic; Fluorescent reporter; Histone acetyltransferase

Indexed keywords

ACETYLATION; AMINO ACIDS; CHROMOSOMES; SIGNAL TRANSDUCTION;

CHROMATIN MODIFICATION; ENZYMATIC ACTIVITIES; EPIGENETIC; FLUORESCENCE SIGNALS; FLUORESCENT REPORTER; HISTONE ACETYLTRANSFERASES; MULTIPLE CELLULAR PROCESS; TRANSCRIPTIONAL REGULATION;

FLUORESCENCE;

DANSYL CHLORIDE; FLUORESCEIN; HISTONE ACETYLTRANSFERASE;

ACETYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; ENZYME ACTIVITY; EVALUATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 46649101288     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.05.030     Document Type: Article

References (29)

1. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
2. Peterson C.L., and Laniel M.A. Histones and histone modifications. Curr. Biol. 14 (2004) R546-R551
3. Ng H.H., and Bird A. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 9 (1999) 158-163
4. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2000) 435-459
5. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001) 81-120
6. Vetting M.W., LP S.d.C., Yu M., Hegde S.S., Magnet S., Roderick S.L., and Blanchard J.S. Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. Biophys. 433 (2005) 212-226
7. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32 (2004) 959-976
8. Lee K.K., and Workman J.L. Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell. Biol. 8 (2007) 284-295
9. Heery D.M., and Fischer P.M. Pharmacological targeting of lysine acetyltransferases in human disease: a progress report. Drug Discov. Today 12 (2007) 88-99
10. Giles R.H., Peters D.J., and Breuning M.H. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14 (1998) 178-183
11. Rowley J.D., Reshmi S., Sobulo O., Musvee T., Anastasi J., Raimondi S., Schneider N.R., Barredo J.C., Cantu E.S., Schlegelberger B., Behm F., Doggett N.A., Borrow J., and Zeleznik-Le N. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90 (1997) 535-541
12. Halkidou K., Gnanapragasam V.J., Mehta P.B., Logan I.R., Brady M.E., Cook S., Leung H.Y., Neal D.E., and Robson C.N. Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene 22 (2003) 2466-2477
13. Suzuki T., and Miyata N. Epigenetic control using natural products and synthetic molecules. Curr. Med. Chem. 13 (2006) 935-958
14. Biel M., Wascholowski V., and Giannis A. Epigenetics-an epicenter of gene regulation: histones and histone-modifying enzymes. Angew. Chem. Int. Ed. Engl. 44 (2005) 3186-3216
15. Y.G. Zheng, J. Wu, Z. Chen, M. Goodman, Chemical regulation of epigenetic modifications: opportunities for new cancer therapy, Med. Res. Rev. 12 February 2008. Epub ahead of print.
16. Martinez E.D., Dull A.B., Beutler J.A., and Hager G.L. High-content fluorescence-based screening for epigenetic modulators. Methods Enzymol. 414 (2006) 21-36
17. Wegener D., Hildmann C., and Schwienhorst A. Recent progress in the development of assays suited for histone deacetylase inhibitor screening. Mol. Genet. Metab. 80 (2003) 138-147
18. Berndsen C.E., and Denu J.M. Assays for mechanistic investigations of protein/histone acetyltransferases. Methods 36 (2005) 321-331
19. Marmorstein R. Biochemical and structural characterization of recombinant histone acetyltransferase proteins. Methods Enzymol. 376 (2004) 106-119
20. Wynne Aherne G., Rowlands M.G., Stimson L., and Workman P. Assays for the identification and evaluation of histone acetyltransferase inhibitors. Methods 26 (2002) 245-253
21. Kim Y., Tanner K.G., and Denu J.M. A continuous, nonradioactive assay for histone acetyltransferases. Anal. Biochem. 280 (2000) 308-314
22. Trievel R.C., Li F.Y., and Marmorstein R. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor. Anal. Biochem. 287 (2000) 319-328
23. Thompson P.R., Wang D., Wang L., Fulco M., Pediconi N., Zhang D., An W., Ge Q., Roeder R.G., Wong J., Levrero M., Sartorelli V., Cotter R.J., and Cole P.A. Regulation of the p300 HAT domain via a novel activation loop. Nat. Struct. Mol. Biol. 11 (2004) 308-315
24. Cotton G.J., Ayers B., Xu R., and Muir T.W. Insertion of a synthetic peptide into a recombinant protein framework: a protein biosensor. J. Am. Chem. Soc. 121 (1999) 1100-1101
25. Chan P.H., Liu H.B., Chen Y.W., Chan K.C., Tsang C.W., Leung Y.C., and Wong K.Y. Rational design of a novel fluorescent biosensor for beta-lactam antibiotics from a class A beta-lactamase. J. Am. Chem. Soc. 126 (2004) 4074-4075
26. Chen Z., and Zheng Y.G. Synthesis of a coumarin-histone conjugate for HAT fluorescent assay. Heterocyclic Commun. 13 (2007) 343-346
27. Thompson P.R., Kurooka H., Nakatani Y., and Cole P.A. Transcriptional coactivator protein p300: kinetic characterization of its histone acetyltransferase activity. J. Biol. Chem. 276 (2001) 33721-33729
28. Slavik J. Anilinonaphthalene sulfonate as a probe of membrane composition and function. Biochim. Biophys. Acta 694 (1982) 1-25
29. Li Y.-H., Chan L.-M., Tyer L., Moody R.T., Himel C.M., and Hercules D.M. Study of solvent effects on the fluorescence of 1-(dimethylamino)-5-naphthalenesulfonic acid and related compounds. J. Am. Chem. Soc. 97 (1975) 3118-3126